Report
Krishnan Sambamoorthy
EUR 120.00 For Business Accounts Only

MOSL : DABUR: In line, margin to improve with a lag

DABUR: In line, margin to improve with a lag

(DABUR IN, Mkt Cap USD12.8b, CMP INR574, TP INR660, 15% Upside, Buy)

  • DABUR reported an in line 1QFY23 earnings. Despite indicating continued margin pressures in 2Q, the management aims to maintain FY23 margin at FY22 levels.
  • Despite rural contributing half of its domestic sales, DABUR reported near identical growth in both rural and urban as a result of its efforts to boost rural distribution. This is unlike the broader Consumer category, where rural demand remains tepid. The company can benefit from the tailwind of a potential recovery in rural demand.
  • The base of the Healthcare business becomes less challenging in subsequent quarters. Traction in most of the other businesses, barring Hair Care, is healthy, with 98% of its portfolio also gaining market share, by far the best among its peers. We maintain our Buy rating.

Performance in line with our estimates

  • Consolidated sales grew 8.1% YoY to INR28.2b in 1QFY23 (in line).
  • EBITDA/PBT/adjusted PAT remained flat YoY at INR5.4b/INR5.6b/INR4.4b (est. INR5.4b/INR5.7b/INR4.4b).
  • The company's India FMCG business is likely to have clocked a volume growth of 5% in 1QFY23 (in line).
  • Gross margin contracted by 220bp YoY to 45.9% (est. 47.7%). As a percentage of sales, lower staff cost (down 30bp YoY to 9.6%), ad spends (down 160bp to 5.6%), and higher other expenses (up 160bp to 11.5%) restricted the contraction in EBITDA margin to 190bp at 19.2% (in line).
  • In 1QFY23, standalone sales grew 9.9% YoY to INR21.8b. EBITDA/adjusted PAT remained flat YoY at INR4.3b/INR3.5b. EBITDA margin contracted by 250bp YoY to 19.6%.

Highlights from the management commentary

  • The Food category achieved sales of INR1b in FY22. It is likely to achieve sales of INR2b in FY23 and INR5b over the next three-to-four years.
  • Sales of Drinks crossed INR1b in FY22, and is likely to end FY23 with INR2b in sales. Sales from this segment already constitute a significant share of the Beverage business sales of INR12b.
  • NPDs constitute ~5% of its total turnover.
  • DABUR raised prices by 5% and reduced grammage by 1.5% in response to the ~9% inflation in raw material cost. While margin in 2Q is likely to remain subdued, 3Q and 4QFY23 will see an improvement in gross margin, led by lapping high inflation in FY22 and further price increases.
Underlying
Dabur India Limited

Dabur India is engaged in manufacturing, marketing and distributing consumer goods and its related products. Co.'s products include hair care, oral care, health supplements, digestives and candies, baby and skin care, fruit juices, cooking pastes and sauces. Co.'s brand names include Dabur, Asavs, Classicals, Dabur Shilajit, Naturecare, Shankhpushpi, Honitus and Ring Ring. Co. operates three business divisions: Consumer Care Division, Consumer Healthcare Division and the wholly owned subsidiary, Dabur Foods Limited.

Provider
Motilal Oswal
Motilal Oswal

​Motilal Oswal Financial Services Ltd. is a reputed name in Financial Services and Online Trading with group companies providing services such as Private Wealth Management, Retail Broking and Distribution, Institutional Broking, Asset Management, Investment Banking, Private Equity, Commodity Broking, Currency Broking, Principal Strategies & Home Finance. 

Motilal Oswal Securities is a group company of Motilal Oswal Financial Service Limited which started as a stock trading company and has blossomed into well diversified firm offering a range of financial products and services. Motilal Oswal has built a reputation as the source for best stock trading company and this has taken a wealth of experience, knowledge and expertise, constantly working in tandem, over the years.

Analysts
Krishnan Sambamoorthy

Other Reports on these Companies
Other Reports from Motilal Oswal

ResearchPool Subscriptions

Get the most out of your insights

Get in touch